Écrit par Wiley | 16 Janvier 2014

A novel study determined that monitoring inactive chronic hepatitis B (HBV) carriers is a cost-effective strategy for China. However, results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that increasing treatment, monitoring and adherence to therapy are necessary to achieve significant health benefits at the population level....

Écrit par CEFALY | 14 Janvier 2014

Liège, Belgique, le 13 janvier 2014 - Le Cefaly®  est une innovation technologique issue de la recherche menée et mise au point en 2009 par la Société liégeoise Cefaly Technology (anciennement Stx-Med) fondée en 2004 par M. Pierre Rigaux, Docteur en Médecine (Université de Liège) et M. Pierre-Yves Muller, Docteur en physique (Université de Genève).

Le Cefaly® est le...

Écrit par EMBO | 08 Janvier 2014

HEIDELBERG, 8 January 2014 – Researchers in the United States have suggested an alternative way to allocate science funding. The method, which is described in EMBO reports, depends on a collective distribution of funding by the scientific community, requires only a fraction of the costs associated with the traditional peer review of grant proposals and, according to the authors...

Écrit par BONE THERAPEUTICS | 18 Décembre 2013

Gosselies, Belgium, 17 December 2013 - BONE THERAPEUTICS, the regenerative therapy company addressing unmet needs in the field of orthopaedics via a minimally invasive approach, today announces that as part of an expert consortium it has been awarded a share of a highly competitive Marie Curie grant totalling €3.8 million.  The Marie Curie grant is an award aimed at stimulating...